ArticleBrazilian journal of otorhinolaryngology2026
Surgical management of presternal recurrence in hyperparathyroidism related to chronic kidney disease.
Article in Brazilian journal of otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the surgical management and outcomes of recurrence localized in presternal autografts after total parathyroidectomy with autograft for hyperparathyroidism related to chronic kidney disease.
methodsA retrospective cohort study was conducted including patients submitted to total parathyroidectomy with presternal autograft between 2000 and 2024 who developed biochemical recurrence according to Brazilian Society of Nephrology criteria and required reoperation. Only cases occurring more than six months after an initially effective surgery were included. The primary outcome was sustained biochemical resolution.
resultsTwenty-four patients required reoperation due to recurrence in the presternal autograft. All were on hemodialysis at initial surgery. Mean CKD duration was 96-months and mean preoperative PTH level was 1445.4 pg/mL. Thirty-one reoperations were performed; most patients (87.5%) required only one procedure. The mean interval between initial surgery and first graft reoperation was 62.6-months. No invasive growth beyond anatomical limits was observed. Mean intraoperative PTH reduction was 80.8%. Considerable variability was observed between intraoperative PTH reduction and subsequent clinical outcomes. Total graft removal was feasible when indicated.
conclusionReoperation for recurrence in presternal autografts was feasible in this series and was associated with satisfactory biochemical control, even in patients requiring multiple procedures. The anatomical characteristics of the presternal region allowed controlled resections without evidence of invasive growth beyond the graft bed. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.